Search Results for

EAZ171

Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

Continue Reading »

---

S1820

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

Continue Reading »

---

WF-1806

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Continue Reading »

---

WF-1802

Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer

Continue Reading »

---

WF-1801

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Continue Reading »

---

S1614

Tenofovir Alafenamide in Preventing Liver Complications in Participants With Current or Past Hepatitis B Virus Who Are Receiving Anti-Cancer Therapy for Solid Tumors

Continue Reading »

---

URCC 18007

Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors

Continue Reading »

---

URCC 16070

Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Continue Reading »

---

NHLBI MDS

The National Myelodysplastic Syndromes (MDS) Study

Continue Reading »

---

Search Again

• All Trial Categories Anal  (2) Bladder/Urinary Tract Cancer  (7)    Metastatic  (3)    Neoadjuvant  (3) Brain  (9)    Glioblastoma Multiforme (GBM)  (3)    Other Brain Tumors  (3) Breast  (9)    Breast Cancer Adjuvant  (3)    DCIS/LCIS  (1) Cancer Control/Symptom Management  (19) Carcinoid Tumors  (1) Colorectal Cancer  (7)    Metastatic  (2)    Rectal Neoadjuvant  (1) Esophageal Cancer  (1) Gall Bladder/ Biliary Tract Cancer  (1) Head/Neck Cancer  (5) Leukemia  (2)    B-Cell Chromic Lymphocytic Leukemia (CLL) / Small Ly  (1) Liver/Hepatocellular Carcinoma  (1) Lung Cancer  (24)    Non-Small Cell Lung Cancer  (16)       1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence  (4)       2nd Line Metastatic, Stage 4 Patients with Progressive Disease  (4)       Adjuvant Treatment for Resected NSCLC  (4)    Small Cell Lung Cancer  (8)       Extensive Stage SCLC  (5) Lymphoma  (2)    Non-Hodgkin’s Lymphoma  (1) MDS  (2) Melanoma  (2)    Metastatic  (1) Merkel Cell Carcinoma  (1) Multiple Myeloma  (1) Ovarian  (1) Pancreatic  (3)    Metastatic Disease  (2) Prostate  (10) Renal Cell/Kidney Cancer  (3)    Locally Advanced/Metastatic  (3) Sarcoma  (2)